ArticleThe Journal of clinical investigation2017
Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.
Ryu Watanabe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
62 papers cite itlatest 60 shown
this paperpooled itcites it